Breadcrumb Home investors intimation stock exchanges Intimation to stock Exchanges Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2026-20272025-20262024-20252023-20242022-20232021-20222020-20212019-20202018-20192017-20182016-20172015-20162014-20152013-20142012-20132011-20122010-2011 Apply Intimation to Stock Exchange for 2026-2027 Update on USFDA inspection at InvaGen manufacturing facility in Hauppauge, Long Island, New York, USA 17th Nov 2026 Disclosure on search proceeding conducted by the Directorate of Revenue Intelligence 16th Nov 2026 Notice of Postal Ballot 16th Nov 2026 Newspaper publication of Notice of Final Hearing of Company Scheme Petition 05th Nov 2026 Appointment of Mr Vikram Janakiraman, as the Global Chief Technical Operating Officer, designated as SMP 04th Nov 2026 Newpaper Advertisement regarding opening of special window for re-lodgement of transfer and dematerialisation of physical shares 03rd Nov 2026 Allotment of 17,453 equity shares under ESOS 2013-A Scheme and the Cipla ESAR Scheme 2021 of the Company 29th Oct 2026 Grant of stock option and employee stock appreciation rights 28th Oct 2026 Appointment of Ms Rashmi Joshi as an additional and Independent Director 27th Oct 2026 USFDA inspection at InvaGen manufacturing facility in Hauppauge, Long Island, New York, USA 23rd Oct 2026 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Next page › Last page last BSE and NSE Quotes by TradingView The displayed data is not in real time and may have streaming delays.